Tech Company Financing Transactions
Ascend Gene & Cell Therapies Funding Round
Ascend Gene & Cell Therapies secured a $132.5 million funding round on 5/9/2023. Investors included Abingworth, Petrichor Healthcare Capital Management and 4BIO Capital.
Transaction Overview
Company Name
Announced On
5/9/2023
Transaction Type
Venture Equity
Amount
$132,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The fundraising enabled the acquisition of CMC capabilities and technologies from Freeline Therapeutics and provides operational resources to build the business.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
3rd Floor, 1 Ashley Road Cheshire
Altrincham, England, WA14 2DT
UK
Altrincham, England, WA14 2DT
UK
Phone
Undisclosed
Website
Email Address
Overview
Ascend was founded by Monograph Capital in response to a changing funding environment, and an increased outsourcing of manufacturing. Through a series of acquisitions, the company has carved out an array of CMC units, and brought in experienced biotech specialists to offer their skills as a service. With origins in biopharma, our expert teams have "been there and done that" with regulators. They understand the quality and potency of your product is just as important as the yield. Beyond that, the Ascend specialists have the next-generation platforms and capabilities you need to ensure clinical and commercial success.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Stella
Chief Financial Officer
Wes McConnell
Chief Operating Officer
Arjan Roozen
Chief Scientific Officer
Markus Hörer
Browse more venture capital transactions:
Prev: 5/9/2023: Jolt Energy venture capital transaction
Next: 5/9/2023: Improvin' venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs